The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

 According to The Business Research Company’s report on Conjunctivitis Treatment, the global market is projected to increase from $4.27 billion in 2022 to $4.49 billion in 2023, with a 5% CAGR. By 2027, the market size is estimated to reach $5.24 billion, growing at a 3.9% CAGR.

What was the major driver in the conjunctivitis treatment market?
The increasing incidence of conjunctivitis cases is set to drive the conjunctivitis treatment market’s growth. Conjunctivitis is characterized by inflammation of the conjunctiva, a thin, transparent tissue covering the eye’s white part and lining the inner eyelids. The market expansion is spurred by the growing need for treatment options, as more individuals seek medical attention due to the rising prevalence of conjunctivitis. For example, in June 2022, the American Medical Association reported a higher prevalence of viral conjunctivitis compared to bacterial conjunctivitis in adults, with 78% and 16% respectively, in 2022. Among children, bacterial conjunctivitis was higher at 71%, while viral conjunctivitis accounted for 16%. Hence, the increased prevalence of conjunctivitis cases fuels the demand for the conjunctivitis treatment market.

View More On The Conjunctivitis Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/conjunctivitis-treatment-global-market-report

What was the key trend in the conjunctivitis treatment market?
Product innovation is a prominent trend in the conjunctivitis treatment market, with major companies focusing on innovative products to enhance their market position. For example, in March 2022, Johnson & Johnson Vision Care, a US-based division dedicated to eye health and vision care, obtained FDA approval for ACUVUE Theravision with Ketotifen, the world’s first drug-eluting contact lens. This pioneering technology combines ACUVUE daily disposable contact lenses with a well-established antihistamine, creating a new market category. ACUVUE Theravision with Ketotifen is designed to prevent ocular itch resulting from allergic conjunctivitis and offer vision correction for eligible contact lens users with up to 1.00 D of astigmatism without causing red eyes.

Which was the largest region in the conjunctivitis treatment market?
North America was the largest region in the conjunctivitis treatment market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in conjunctivitis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the conjunctivitis treatment market prominent players?
Major players in the conjunctivitis treatment market are Pfizer Inc., Johnson and Johnson, AbbVie Inc., Novartis AG, Sanofi SA, Boehringer Ingelheim, Viatris Inc., Teva Pharmaceutical Industries Ltd., Alcon Laboratories Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Cipla Inc., Bausch Health Companies Inc, Santen Pharmaceuticals Co. Ltd, Lupin Limited, Allergan PLC, Alembic Pharmaceuticals Ltd, Akorn Inc., Micro Labs Ltd., Indoco Remedies Ltd., Mankind Pharma Ltd., AFT pharmaceuticals Limited, Ocular Therapeutics Inc., Sirion Therapeutics Inc., Jabs Biotech Pvt. Ltd., Atopix Therapeutics Ltd., JAWA Pharmaceuticals Pvt. Ltd., Eyevance Pharmaceuticals LLC, and NicOx SA.

Key conjunctivitis treatment market segments
The global conjunctivitis treatment market is segmented –
1) By Drug Class: Antibiotics, Antiviral, Anti-Allergic, Artificial Tears
2) By Disease Type: Allergic Conjunctivitis, Bacterial Conjunctivitis, Viral Conjunctivitis
3) By Route Of Administration: Oral, Topical
4) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

Request A Sample Of The Global Conjunctivitis Treatment Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12051&type=smp

The Conjunctivitis Treatment Global Market Report 2023  provides a comprehensive overview on the conjunctivitis treatment market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Drug Delivery Devices Global Market Report 2023
Allergy Conjunctivitis Global Market Report 2023
Antimicrobial Susceptibility Testing Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model